Aptevo Therapeutics Inc. Finance Lease, Right-of-Use Asset, Amortization
Aptevo Therapeutics Inc. (APVO) reported Finance Lease, Right-of-Use Asset, Amortization of $2.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2022-11-10
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-06-30 was $1.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $2.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-12-31 was $1.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $6.00K, a 0.00% change from fiscal 2020.
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $6.00K, a 0.00% change from fiscal 2019.
- Aptevo Therapeutics Inc. finance lease, right-of-use asset, amortization for fiscal 2019 was $6.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.00K derived: sum of 2 quarters · filed 2022-11-10 | $2.00K 10-Q · filed 2022-11-10 | $4.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $1.00K 10-Q · filed 2022-08-11 | $2.00K 10-Q · filed 2022-08-11 | $4.00K derived: sum of 3 quarters · filed 2022-08-11 | $6.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-03-31 | $2.00K 10-Q · filed 2022-05-12 | $3.00K derived: sum of 2 quarters · filed 2022-05-12 | $5.00K derived: sum of 3 quarters · filed 2022-11-10 | $6.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $3.00K derived: sum of 2 quarters · filed 2022-11-10 | $4.00K derived: sum of 3 quarters · filed 2022-11-10 | $6.00K 10-K · filed 2022-03-24 |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-10 | $3.00K derived: sum of 2 quarters · filed 2022-11-10 | $5.00K 10-Q · filed 2022-11-10 | $6.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-11 | $3.00K 10-Q · filed 2022-08-11 | $4.00K derived: sum of 3 quarters · filed 2022-08-11 | $6.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-12 | $3.00K derived: sum of 2 quarters · filed 2022-05-12 | $5.00K derived: sum of 3 quarters · filed 2022-05-12 | $7.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $3.00K derived: sum of 2 quarters · filed 2022-03-24 | $5.00K derived: sum of 3 quarters · filed 2022-03-24 | $6.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-12 | $4.00K derived: sum of 2 quarters · filed 2021-11-12 | $5.00K 10-Q · filed 2021-11-12 | $9.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $2.00K 10-Q · filed 2021-08-12 | $3.00K 10-Q · filed 2021-08-12 | $7.00K derived: sum of 3 quarters · filed 2021-08-12 | $7.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-11 | $5.00K derived: sum of 2 quarters · filed 2021-05-11 | $5.00K derived: sum of 3 quarters · filed 2021-05-11 | $7.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $3.00K derived: sum of 2 quarters · filed 2021-03-31 | $5.00K derived: sum of 3 quarters · filed 2021-03-31 | $6.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | $2.00K derived: sum of 2 quarters · filed 2020-08-14 | $3.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $2.00K 10-Q · filed 2020-08-14 | $3.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |